Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.00K | 0.00 | 18.18K | 64.84K | 2.29M | 1.97M | Gross Profit |
-213.00 | -213.00 | -12.72K | 61.68K | 322.01K | 154.07K | EBIT |
-411.63K | -379.63K | -719.78K | -397.98K | -141.96K | -387.33K | EBITDA |
-301.17K | -387.17K | -719.49K | -314.25K | -114.43K | -981.88K | Net Income Common Stockholders |
-385.72K | -516.72K | -843.63K | -574.70K | -543.45K | -1.66M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
53.00K | 8.91K | 17.15K | 12.75K | 246.19K | 27.97K | Total Assets |
1.59M | 864.50K | 1.32M | 1.79M | 2.33M | 3.26M | Total Debt |
4.28M | 3.42M | 4.45M | 4.69M | 4.82M | 6.13M | Net Debt |
4.23M | 3.41M | 4.43M | 4.68M | 4.57M | 6.10M | Total Liabilities |
4.52M | 3.70M | 4.67M | 5.06M | 5.30M | 6.68M | Stockholders Equity |
-2.92M | -2.84M | -3.35M | -3.27M | -2.96M | -3.42M |
Cash Flow | Free Cash Flow | ||||
-1.43M | -909.75K | -642.97K | -352.84K | 939.92K | 555.22K | Operating Cash Flow |
-1.43M | -909.75K | -617.97K | -352.84K | 940.52K | 556.21K | Investing Cash Flow |
0.00 | 927.25K | 624.62K | 352.50K | -599.00 | -986.00 | Financing Cash Flow |
1.24M | -25.74K | -2.26K | -233.10K | -721.70K | -560.06K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £4.44B | 16.60 | 7.71% | 1.44% | 15.42% | 4.45% | |
72 Outperform | £4.31B | 19.64 | 4.92% | 7.64% | -3.22% | -37.21% | |
64 Neutral | £225.33M | 13.62 | 5.65% | 2.07% | 13.91% | -2.75% | |
64 Neutral | £3.49B | 23.80 | 4.22% | 1.43% | -11.63% | -31.81% | |
61 Neutral | $2.83B | 10.72 | 0.40% | 6.10% | 5.80% | -21.26% | |
51 Neutral | £486.09M | ― | -13.06% | 1.27% | -5.98% | -677.54% | |
31 Underperform | £400.11K | ― | ― | 446.45% | 59.09% |